Profile
Charles T.
Nomides was appointed Chief Research and Development Officer for Barrier Therapeutics, Inc. in February 2006.
From July 2002 to February 2006, he served as Chief Operating Officer of Barrier Therapeutics.
From 1997 to 2002, he was employed by Johnson & Johnson Consumer Products Worldwide, where he served as Director of Research and Development in charge of the Ortho Neutrogena Prescription Drug Development Group.
Mr. Nomides received a Bachelor's degree in Biology from Clarion State University and graduate training from Temple University and The Milton S.
Hershey Medical Center.
Former positions of Charles T. Nomides
Companies | Position | End |
---|---|---|
Barrier Therapeutics, Inc.
Barrier Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Barrier Therapeutics, Inc. discovers, develops, and commercializes pharmaceutical products in the field of dermatology in the United States. It markets Xolegel, Vusion, and Solage gels. The firm markets its products to dermatologists and other target physicians through sales force. The company was founded in 2001 and is headquartered in Princeton, NJ | Chief Tech/Sci/R&D Officer | 13/09/2007 |
Johnson & Johnson Consumer Products Co.
Johnson & Johnson Consumer Products Co. Household/Personal CareConsumer Non-Durables Part of Kenvue, Inc., Johnson & Johnson Consumer Products Co. develops and markets baby care, wound care, and skin care products. Jorge S. Mesquita has been the CEO of the American company since 2014. | Chief Tech/Sci/R&D Officer | 01/01/2002 |
Training of Charles T. Nomides
Clarion University of Pennsylvania | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Barrier Therapeutics, Inc.
Barrier Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Barrier Therapeutics, Inc. discovers, develops, and commercializes pharmaceutical products in the field of dermatology in the United States. It markets Xolegel, Vusion, and Solage gels. The firm markets its products to dermatologists and other target physicians through sales force. The company was founded in 2001 and is headquartered in Princeton, NJ | Health Technology |
Johnson & Johnson Consumer Products Co.
Johnson & Johnson Consumer Products Co. Household/Personal CareConsumer Non-Durables Part of Kenvue, Inc., Johnson & Johnson Consumer Products Co. develops and markets baby care, wound care, and skin care products. Jorge S. Mesquita has been the CEO of the American company since 2014. | Consumer Non-Durables |
- Stock Market
- Insiders
- Charles T. Nomides